75 related articles for article (PubMed ID: 9515717)
21. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
[TBL] [Abstract][Full Text] [Related]
22. A novel quantitative flow cytometric method for measuring glucocorticoid receptor (GR) in cell lines: correlation with the biochemical determination of GR.
Voutsas IF; Gritzapis AD; Alexis MN; Katsanou ES; Perez S; Baxevanis CN; Papamichail M
J Immunol Methods; 2007 Jul; 324(1-2):110-9. PubMed ID: 17582432
[TBL] [Abstract][Full Text] [Related]
23. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
24. Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.
Yee D; Hao C; Cheung HC; Chen HT; Dabbagh L; Hanson J; Coupland R; Petruk KC; Fulton D; Roa WH
Clin Invest Med; 2001 Apr; 24(2):76-82. PubMed ID: 11368149
[TBL] [Abstract][Full Text] [Related]
25. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
Slebos RJ; Taylor JA
Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
[TBL] [Abstract][Full Text] [Related]
26. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
27. p53 expression in the normal murine eye.
Pokroy R; Tendler Y; Pollack A; Zinder O; Weisinger G
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1736-41. PubMed ID: 12036973
[TBL] [Abstract][Full Text] [Related]
28. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
[TBL] [Abstract][Full Text] [Related]
29. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.
Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG
Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716
[TBL] [Abstract][Full Text] [Related]
30. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis induction in human lymphoma and leukemia cell lines by transfection via dendrosomes carrying wild-type p53 cDNA.
Massumi M; Ziaee AA; Sarbolouki MN
Biotechnol Lett; 2006 Jan; 28(1):61-6. PubMed ID: 16369877
[TBL] [Abstract][Full Text] [Related]
32. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
[TBL] [Abstract][Full Text] [Related]
34. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
35. [Functional status of p53 and chemosensitivity of colon cancer cell lines].
Jia L; Yu L; Zhu S
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):389-90. PubMed ID: 11778275
[TBL] [Abstract][Full Text] [Related]
36. Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells.
Yao W; Gu L; Sun D; Ka W; Wen Z; Chien S
Cell Motil Cytoskeleton; 2003 Sep; 56(1):1-12. PubMed ID: 12905527
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.
Horio Y; Hasegawa Y; Sekido Y; Takahashi M; Roth JA; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):537-44. PubMed ID: 10811471
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
39. Rapid and sensitive immunomagnetic-electrochemiluminescent detection of p53 antibodies in human serum.
Yan G; Xing D; Tan S; Chen Q
J Immunol Methods; 2004 May; 288(1-2):47-54. PubMed ID: 15183084
[TBL] [Abstract][Full Text] [Related]
40. Comparative, genome-scale transcriptional analysis of CHRF-288-11 and primary human megakaryocytic cell cultures provides novel insights into lineage-specific differentiation.
Fuhrken PG; Chen C; Miller WM; Papoutsakis ET
Exp Hematol; 2007 Mar; 35(3):476-489. PubMed ID: 17309828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
